MedTrace Logo

Motion Capture and Analysis of NYIT Athletes

NCT02727049 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-10-12

No results posted yet for this study

Summary

The purpose of this research is to:

1. determine the normal or existing dynamic biomechanics of college athletes and
2. test the effectiveness of osteopathic manipulative medicine in the treatment of athletic injuries.

Motion capture using Vicon systems allows researchers to quantify characteristics of a body such as the range of motion of the hip or shoulder during an athletic technique such as kicking or shooting a basketball into the basket. The quantified information has been used before to better understand human mobility and performance. Osteopathic manipulative medicine (OMM) is manual medicine applied to joints, muscles, and connective tissue with a goal of improved body functions. Research demonstrating effectiveness of OMM on the musculoskeletal and associated connective tissue systems health includes, among others, prospective clinical trials of OMM for treatment of neck pain, low back pain, and acute first- and second-degree ankle sprains.

Conditions

  • Athletic Injuries

Interventions

OTHER

Osteopathic manipulative medicine (OMM)

Osteopathic manipulative medicine includes all types of manual therapies to gently restore and/or optimize one's natural joint, muscle, and other soft tissue balance.

Sponsors & Collaborators

  • New York Institute of Technology

    lead OTHER

Principal Investigators

  • Jayme D Mancini, DO PhD · New York Institute of Technology

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02727049 on ClinicalTrials.gov